ISSUE OF SECURITIES BY TRUSCREEN LIMITED (TRU)

Company Announcement 5 February, 2018

TruScreen Share Placement

ISSUE OF SECURITIES BY
TRUSCREEN LIMITED (TRU)

TruScreen Limited advises that it has issued new shares as follows:

Class of Security: Ordinary Shares (TRU)

Number issued: 600,000 ordinary shares at NZD 10 cents each fully paid

Payment: Cash on subscription

Percentage of total Class
of Securities issued: 0.3% (of the total number of ordinary shares on issue post completion
of the issue)

Reason for the issue: Exercise of options allocated to Mr Sean Joyce by Directors Resolution
on 27 March, 2014:

Authority of issue: Director’s Resolution

Terms of issue: The new shares are credited as fully paid, and rank in all respects
equally with the shares already on issue.

Total number of securities
of the Class in existence
after the issue: 197,788,541

Date of issue: 5 February, 2018


TRUSCREEN LIMITED




Martin Dillon
Chief Executive Officer

-ENDS-
For more information visit www.truscreen.com or contact:
Martin Dillon
TruScreen Chief Executive Officer
Email: martindillon@truscreen.com
Media Liaison
Jackie Ellis
Email: jackie@ellisandco.co.nz
Phone: +64 27 246 2505
About TruScreen:
TruScreen’s real time cervical cancer
technology utilises a digital wand which is
placed on the surface of the cervix to measure
electrical and optical signals from the
surrounding tissue. A sophisticated proprietary
algorithm framework distinguishes between
normal and abnormal (cancerous and
precancerous) tissue to identify precancerous
change, or cervical intraepithelial neoplasia
(CIN). A Single Use Sensor (SUS) is used for
each patient to protect against cross-infection.

---

TRUSCREEN LIMITED

Director’s Resolutions

1. ISSUE OF ORDINARY FULLY PAID SHARES

1.1 The Directors resolve that:

(a) the Company issue 600,000 fully paid ordinary shares (“Shares”) to those persons and
in those proportions stated in the Table in Schedule 1, at an issue price of 10 cents per
share, which sum has been satisfied by the payment of cash;

(b) the Directors take all actions, do all things and execute all documents and agreements
necessary or considered by them to be expedient to issue the Shares, including the
Director’s Certificate accompanying this resolution;

(c) the consideration for and terms of the issue of the Shares are fair and reasonable to
the Company and to all existing shareholders and are as set out in the Directors
Resolution of 27 March 2014 detailing the allocation of Options to Mr Sean Joyce.

1.2 Such Shares when issued, shall rank pari passu with all existing ordinary shares of the
Company.

DATED 5 February, 2018


_____________________________ _____________________________
Chris Lawrence Christopher Horn


_____________________________ _____________________________
Ron Jones Robert Hunter

SCHEDULE 1

Name

Subscription
Amount
Amount of Shares Allocation Date
$ #
Sean Joyce 60,000 600,000 5 February, 2018

TRUSCREEN LIMITED

DIRECTOR'S CERTIFICATE

The following directors, having voted in favour of a resolution dated 5 February 2018 relating to the
issue of shares, hereby certify:

1. The terms of issue are as follows:
Number of shares to be issued: 600,000
Issue price of shares: 10 cents per share
Persons to whom shares to be issued: Mr Sean Joyce
Payment date for consideration: On or before the date of the issue of the
Shares
Details of consideration: Cash

2. In our opinion, the consideration for and terms of issue are fair and reasonable to the
Company and to all existing shareholders and are as set out in in the Directors
Resolution of 27 March 2014 detailing the allocation of Options to Mr Sean Joyce.

DATED 5 February, 2018


_____________________________ _____________________________
Chris Lawrence Christopher Horn


_____________________________ _____________________________
Ron Jones Robert Hunter

---

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Truscreen Limited
Date this disclosure made:
5-Feb-18
Date on which issuer listed or appointment made:
N/A - no longer a director
Director or senior manager giving disclosure
Full name:
Sean Robert Joyce
Name of listed issuer:
Truscreen Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Formerly a director
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product:
Ordinary shares
Nature of relevant interest:
Legal and beneficial holder
Number held in class:
600,000
Acquired upon the exercise of 600,000 options
Current registered holder:
Sean Joyce
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
N/A
Class of underlying financial products:
N/A
Details of derivative
N/A
The notional value of the derivative (if any) or the notional amount of
underlying products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative (if any):
N/A
The price specified in the terms of the derivative(if any):
N/A
Any other details needed to understand how the amount of the consideration
payable under the derivative or the value of the derivative is affected by the
value of the underlying financial products:
N/A
For that derivative,-
Parties to the derivative:N/A
If the director or senior manager is not a party to the derivative, the nature of
the relevant interest in the derivative:
N/A
Certification
I certify that, to the best of my knowledge and belief, the information
contained in this disclosure is correct and that I am duly authorised to make
this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
5-Feb-18
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:

Notes
Use this form to disclose the relevant interests that a director or senior
manager of a listed issuer has in quoted financial products of the listed
issuer or a related body corporate or a specified derivative. The disclosure
must be made within 5 trading days of—
(a) the listing of the public issuer; or
(b) the person’s appointment as a director or senior manager.